Global Microfluidics Market Size, Share & Trends Analysis Report By Type (Microfluidic Sensors, Microfluidic Needles, Microfluidic Pumps), By Material (Glass, Polymer, Silicon), By Application (in Vitro Diagnostics, Capillary Electrophoresis, Genomics), and By Region and Forecast from 2022-2027
Global Microfluidics Market
Global Microfluidics Market was valued at USD 21.7 billion in 2021 which is expected to reach USD 59.0 billion by 2027, at a CAGR of 18.14 % from 2022-2027.
A technical approach for examining the composition and properties of fluids is microfluidics. Using a collection of instruments to manipulate and regulate the chemical and biological processes of tiny fluid volumes is necessary for its application. Also, it is employed in the creation of microminiaturized devices that have a lot of tunnels and chambers for the confinement or movement of fluids. It requires fewer samples, the instruments are smaller, and it offers superior parameter control and data quality compared to conventional fluid measuring devices. As a result, it's frequently utilized for PCR amplification, cell separation, and DNA analysis.
Market Driver
The rise in chronic illnesses and infectious diseases is fuelling the market for microfluidic devices. Microfluidic tools are also employed in the early detection of cancer. For instance, the American Cancer Society (ACS) projects that in 2021 there will be an estimated 1.9 million new cancer cases identified and 608,570 cancer deaths in the United States.
Furthermore, the market is growing as a result of the rising elderly population. For instance, the European Union's statistical agency, Eurostat, reported that in 2021, more than 20.8% of the population was 65 years of age or older. Due to slower metabolism and lowered immunity, older individuals are more susceptible to infectious and chronic diseases.
Market Restraints
Strict governmental approvals are one of the factors anticipated to hamper the market growth. Future market expansion may face further difficulties as a result of the standardization and commercialization of microfluidic devices. On the other hand, the lengthy and challenging regulatory approval process is anticipated to restrain the growth of the microfluidics market over the forecast period.
COVID-19 Impact
The COVID-19 outbreak had a positive impact on the microfluidics industry. Microfluidic technology-based rapid diagnostics, point-of-care diagnostics, and IVD devices for drug discovery and COVID-19 testing were in high demand. Several industry participants were focusing on introducing quick antigen testing based on microfluidics technology to diagnose COVID-19. In order to combat the pandemic, regulatory bodies had also promised to support the approval of microfluidics testing.
Market Segmentation
Global Microfluidics Market is segmented into Types such as Microfluidic Sensors, Microfluidic Needles, and Microfluidic Pumps. Furthermore, the market is segmented into Materials such as Glass, Polymer, and Silicon. Moreover, the market is divided into Applications such as in Vitro Diagnostics, Capillary Electrophoresis, and Genomics)
Regional Analysis
Global Microfluidics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America accounted for the majority of the microfluidic devices market's revenue and is predicted to dominate the worldwide market over the projection period due to an increase in product launches, a solid healthcare infrastructure, and the presence of significant companies. The primary driver fueling market expansion is an increase in research funding from government agencies and businesses.
With rising healthcare costs, expanding healthcare infrastructure, and a large population base, Asia-Pacific is anticipated to experience the greatest expansion.
Key Players
This research describes a number of key players, including, Lonza Group, Thermo Fisher Scientific Inc., Perkinelmer Inc., Biorad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Fluidigm Corporation, Dolomite Microfluidics, bioMérieux SA, Abbott Laboratories, Danaher Corporation.
Market Taxonomy
By Type
• Microfluidic Sensors
• Microfluidic Needles
• Microfluidic Pumps
By Material
• Glass
• Polymer
• Silicon
By Application
• in Vitro Diagnostics
• Capillary Electrophoresis
• Genomics
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Microfluidics Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Microfluidics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Microfluidics Market, By Types
5.1 Y-o-Y Growth Comparison, By Types
5.2 Global Microfluidics Market Share Analysis, By Types
5.3 Global Microfluidics Market Size and Forecast, By Types
5.3.1 Microfluidic Sensors
5.3.2. Microfluidic Needles
5.3.3. Microfluidic Pumps
6 Global Microfluidics Market, By Material
6.1 Y-o-Y Growth Comparison, By Material
6.2 Global Microfluidics Market Share Analysis, By Material
6.3 Global Microfluidics Market Size and Forecast, By Material
6.3.1 Glass
6.3.2 Polymer
6.3.3 Silicon
7 Global Microfluidics Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Microfluidics Market Share Analysis, By Application
7.3 Global Microfluidics Market Size and Forecast, By Application
7.3.1 in Vitro Diagnostics
7.3.2. Capillary Electrophoresis
7.3.3. Genomics
8 Global Microfluidics Market, By Region
8.1 Global Microfluidics Market Share Analysis, By Region
8.2 Global Microfluidics Market Share Analysis, By Region
8.3 Global Microfluidics Market Size and Forecast, By Region
9 North America Microfluidics Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Microfluidics Market Share Analysis, By Types
9.3 North America Microfluidics Market Size and Forecast, By Material
9.4 North America Microfluidics Market Size and Forecast, By Application
9.5 North America Microfluidics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Microfluidics Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Microfluidics Market Share Analysis, By Types
10.3 Europe Microfluidics Market Size and Forecast, By Material
10.4 Europe Microfluidics Market Size and Forecast, By Application
10.5 Europe Microfluidics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Microfluidics Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Microfluidics Market Share Analysis, By Types
11.3 Asia Pacific Microfluidics Market Size and Forecast, By Material
11.4 Asia Pacific Microfluidics Market Size and Forecast, By Application
11.5 Asia Pacific Microfluidics Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Microfluidics Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Microfluidics Market Share Analysis, By Types
12.3 Latin America Microfluidics Market Size and Forecast, By Material
12.4 Latin America Microfluidics Market Size and Forecast, By Application
12.5 Latin America Microfluidics Market Size and Forecast, Country
13 Middle East Microfluidics Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Microfluidics Market Share Analysis, By Types
13.3 Middle East Microfluidics Market Size and Forecast, By Material
13.4 Middle East Microfluidics Market Size and Forecast, By Application
13.5 Middle East Microfluidics Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Lonza Group
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Thermo Fisher Scientific Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Perkinelmer Inc.
15.3.1 Overvie
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Biorad Laboratories, Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Illumina, Inc.
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Qiagen N.V.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Fluidigm Corporation
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Dolomite Microfluidics
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 bioMérieux SA
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Abbott Laboratories
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 Danaher Corporation
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
